Science Explorer Back to mapMap
Discussion
Researcher · Lifenet Health · United States

Justin J. Odanga

Justin J. Odanga publishes mostly in Molecular Biology, Biomedical Engineering and Hepatology, on topics such as Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors and 3D Printing in Biomedical Research.

ORCID 0000-0002-7306-2267 OpenAlex
World rank
#4,903,003
of 7,710,434 ranked researchers
Rank in United States
#1,278,489
of 1,627,098
Works
19
Citations
139
Citations per work
7.3
h-index
7
i10-index 5Top 91% in Molecular Biology
Justin J. Odanga

What does Justin J. Odanga research?

Justin J. Odanga's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (33%), Engineering (13%).

Life Sciences: 7 works · 35.2% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 35.2% of their workMolecular Biology: 7 works · 35.2% of their workHealth Sciences: 6 works · 33.3% of their workMedicine: 6 works · 33.3% of their workHepatology: 2 works · 11.1% of their workEpidemiology: 1 works · 7.4% of their workOncology: 1 works · 7.4% of their workPulmonary and Respiratory Medicine: 1 works · 7.4% of their workEverything else: 4 works · 18.5% of their workPhysical Sciences: 2 works · 13.0% of their workEngineering: 2 works · 13.0% of their workBiomedical Engineering: 2 works · 13.0% of their workTHEIR WORKJustin J. Odanga19works
Life Sciences35%Physical Sciences13%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology735.2%
    1. Medicine633.3%
  3. Everything else418.5%
    1. Engineering213.0%
  1. 1Molecular Biology35% of their works
  2. 2Biomedical Engineering13% of their works
  3. 3Hepatology11% of their works
  4. 4Oncology7% of their works
  5. 5Epidemiology7% of their works
  6. 6Pulmonary and Respiratory Medicine7% of their works

Research topics

Which keywords describe Justin J. Odanga's research?

The keywords of their largest research topics: Cancer Therapy, Cell Cycle Control, Proteasome, Ubiquitin, BET Bromodomains, Bioprinting, PROTACs and Tissue Engineering.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy102 topics
  2. Cell Cycle Control72 topics
  3. Proteasome71 topic
  4. Ubiquitin71 topic
  5. BET Bromodomains51 topic
  6. Bioprinting51 topic
  7. PROTACs51 topic
  8. Tissue Engineering51 topic
  9. Breast Cancer41 topic
  10. CDK4/6 Inhibitors41 topic
  11. Hepatic Stellate Cells41 topic
  12. Liver Regeneration41 topic
  13. 14-3-3 Proteins31 topic
  14. Cell Cycle31 topic
  15. Cell Signaling31 topic
  16. NAFLD31 topic
  17. NASH31 topic
  18. p5331 topic

Where does Justin J. Odanga work?

Justin J. Odanga's main affiliation in the publication record is Lifenet Health, United States.

How many publications and citations does Justin J. Odanga have?

OpenAlex counts 19 works and 139 citations for Justin J. Odanga, an h-index of 7, ranking #4,903,003 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Justin J. Odanga. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.